About MS-Omics
MS-Omics is a Healthcare company based in Vedbæk (Denmark) founded in 2014 by Lea Girotz Johnsen and Morten Danielsen, and was acquired by Clinical Microbiomics in October 2022. Metabolomics and data analysis platform is provided by MS-Omics. The company has 2 employees. MS-Omics offers products and services including Metabolomics Services, Data Analysis Services, and Microbiome Applications. Its focus areas include Life Sciences, Genomics, Genomics Research and Metagenomics. Its legal entity is MS Inc. DK ApS.
Company details
MS-Omics was established in 2014 in Vedbaek, Denmark, within the analytical chemistry and biotechnology sector. A specialized platform for metabolomics and data analysis is maintained, alongside services and collaborations focused on advanced data handling. Operations support applications in microbiome studies, clinical research, bacterial analysis, nutrition, and fermentation processes, serving research and industrial needs across these fields.
- Headquarters Vedbæk, Denmark
- Employees 2
- Founders Lea Girotz Johnsen, Morten Danielsen
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website msomics.com
- Social LinkedIn X
- Acquired by Clinical Microbiomics (Oct 2022)
- Legal Name Ms Inc. Dk Aps
- Investors
- Employee Count2
- Acquired byClinical Microbiomics
(Oct 2022)
Products & Services of MS-Omics
MS-Omics offers a comprehensive portfolio of products and services, including Metabolomics Services, Data Analysis Services, and Microbiome Applications.
Provides LC-MS/MS analysis for polar metabolites and research support.
Offers advanced data handling for metabolomics studies and applications.
Delivers analysis for microbiome and clinical research needs.
Investors in MS-Omics
MS-Omics has secured backing from 1 investor. Prominent investors backing the company include Clinical Microbiomics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Meta-genomics platforms and services for microbiome studies are provided. | 2016 | clinical-microbiomics.com | Horsholm, Denmark |
Investor details for MS-Omics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MS-Omics
2 people are tracked at MS-Omics (2 in leadership); the tracked headcount is 2.
| Name | Role | Group |
|---|---|---|
Lea Girotz Johnsen | Co-Founder | Leadership |
Morten Danielsen | Co-Founder | Leadership |
Complete people profiles for MS-Omics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MS-Omics
2 dated milestones of MS-Omics across 8 years, from founding to its latest funding, stage changes and deals.
- Founded MS-Omics is founded.
- Exit Acquired by Clinical Microbiomics.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ms-Omics
Complete news archive for MS-Omics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MS-Omics
MS-Omics was founded in 2014.
MS-Omics is headquartered in Vedbæk, Denmark.
MS-Omics has 2 employees.
MS-Omics was established in 2014 in Vedbaek, Denmark, within the analytical chemistry and biotechnology sector. A specialized platform for metabolomics and data analysis is maintained, alongside services and collaborations focused on advanced data handling. Operations support applications in microbiome studies, clinical research, bacterial analysis, nutrition, and fermentation processes, serving research and industrial needs across these fields.
MS-Omics offers Metabolomics Services, Data Analysis Services, and Microbiome Applications.
MS-Omics has 1 investor. Key investors include Clinical Microbiomics.
MS-Omics operates through Ms Inc. Dk Aps.
Yes. MS-Omics was acquired by Clinical Microbiomics in October 2022.

